Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?

Management of metastatic radioiodine refractory differentiated thyroid cancer (DTC) can be a therapeutic challenge. Generally, little is known about the paired molecular profile of the primary tumor and the metastases and whether they harbor the same genetic abnormalities. The present study compared...

Full description

Saved in:
Bibliographic Details
Published in:Front Endocrinol (Lausanne)
Main Authors: Gomes-Lima, Cristiane J., Shobab, Leila, Wu, Di, Ylli, Dorina, Bikas, Athanasios, McCoy, Matthew, Feldman, Rebecca, Lee, Wen, Rao, Sarika N., Jensen, Kirk, Vasko, Vasily, Castro, Luiz Claudio, Jonklaas, Jacqueline, Wartofsky, Leonard, Burman, Kenneth D.
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2021
Subjects:
Endocrinology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7949910/
https://ncbi.nlm.nih.gov/pubmed/33716974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.623182
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items